Add time:08/10/2019         Source:sciencedirect.com

In order to design and develop potential anticancer drugs involving the same structural pattern as platinum(II) antitumor complexes, complexes of palladium and platinum with 3-methyl-orotic acid as the leaving ligand have been synthesized. The study of the anticancer activity of these compounds toward L1210 leukemia and sarcoma 180 in mice is presented and discussed in terms of the nature of the ligand and the metal involved. The (3-methylorotato)(1,2-diamino-cyclohexane) palladium(II) has an acitivity (sarcoma 180) similar to that for cis-DDP itself. The crystal structure of (3-methylorotato)(dl-trans-1,2-diaminocyclohexane) platinum(II) is described.

We also recommend Trading Suppliers and Manufacturers of 3-methylorotato-(1,2-diaminocyclohexane)platinum (II) (cas 132461-44-0). Pls Click Website Link as below: cas 132461-44-0 suppliers